Launch excellence has become a rare achievement. A successful launch strategy requires unprecedented data, advanced analytics, domain expertise and innovative technology. Gain the support you need from clinical development through post-launch optimization.
On average, post-pandemic launch trajectories underperform and are declining. Resilient launches generally combine a strong clinical story, reduced healthcare burden, and high levels of engagements.
IQVIA is an end-to-end strategic partner for launch planning, execution and monitoring. Maximize your success rate by ensuring consistency of best practices and leverage community-based knowledge sharing to achieve launch excellence for your brand.
The “six month” window still applies meaning most launches have only one shot at success.
80% of launches continue as they start in the first six months.
Most companies even well resourced and experienced struggle to deliver excellence across launches and consistent launch excellence are even harder to achieve the more frequently you launch.
With over three decades of experience and a deep analysis of over 1000 innovative launches, IQVIA knows what it takes to achieve launch excellence.
IQVIA offers end-to-end strategic support throughout launch planning, execution and monitoring.
Global launch excellence is a comprehensive and cohesive way to fully optimize on all launch opportunities.
Research on post-pandemic launch excellence identified three key environmental challenges that require a new approach: patient access, HCP access and market access.
To succeed, companies must change how they prepare for launch with renewed focus on three key areas:
IQVIA offers a connected approach structured around five foundational success factors to achieve launch excellence.
Join us in our launch webinar series, where we will explore how global pharmaceutical companies can leverage IQVIA Launch Connector, a dynamic, inter-connected framework to achieve launch success based on IQVIA's experience spanning three decades and over 5,000 supported launches.
Join Sarah Rickwood, Kirstie Scott and Cristina Alzaga-Chaudhry for a discussion of our latest white paper, Launch Excellence IX.
Looking ahead to 2030, the path to Excellent launches looks very different. Many key launch fundamentals remain, but there are new types of launch, new critical investments for launch and new rules impacting global launch performance. Find out the secrets to unlock efficiency, embrace change and thrive in a fast-paced and volatile environment.
Visit IQVIA’s Launch Excellence Podcast Series to learn more about the top issues and latest trends that are shaping the future of successful commercial launches. Gain insightful perspectives from industry experts in order to drive innovative and agile launches in a more complex patient journey.
Listen to our most recent episode below or click on view podcasts link to access all available episodes.
Fully optimize all launch opportunities and realize full market potential
How patient support programmes can provide the competitive edge in a tough launch landscape
How to navigate harsh realities in a highly fluid environment
Explore how the fundamental rules for Launch Excellence have changed. Delve into the trends influencing Launch Excellence and what the excellent launches are doing differently.
How to capture the full potential of a pipeline in a product.
Get insights into the evolving dynamics and challenges of a new launch environment and act early to adapt their plans to evolving patient, physician, and payor needs.
Be proactive about growing your brand using the latest in data, analytics, and domain expertise.
Understand how payers, providers, and patients define value, and accelerate market access for new and innovative products.
Maximize the value of your brand with personalized, precise, and efficient communications.
.svg){kind=icon}
